2024. AI-Driven Assessment of The Efficacy And Safety of Gene and Cell-Based Therapies for Ischemic Heart Disease: A Systematic Review of Clinical Trials. Journal of Carcinogenesis. 23, 1 (Dec. 2024), 1065–1078. DOI:https://doi.org/10.66838/J.Carcinog.23.1.1065-1078.